This virtual tumor board discussion will include:

• Approaches to pre-operative testing
• Understanding the landscape of management of PSM during COVID-19 in the US
• How long it is safe to keep patients on chemotherapy who are CRS/HIPEC candidates
• Analyzing and interpreting risks of chemotherapy during COVID-19

Moderators for this virtual tumor board are Kiran Turaga, MD, MPH, University of Chicago and Edward Levine, MD, Wake Forest Baptist Health. Panelists include Joel Baumgartner, MD, UC San Diego Health, Laura Lambert, MD, University of Utah Health, Daniel Labow, MD, Mount Sinai St. Luke’s and Blasé Polite, MD, University of Chicago.